Lakefront Biotherapeutics | GLPG - Ordinary Share Capital

Stock Price
23.40
Daily Change
-0.38 -1.60%
Monthly
-5.26%
Yearly
-5.11%
Q2 Forecast
23.43

Lakefront Biotherapeutics reported EUR65.9M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 73K Mar/2026
Biogen USD 146.7M 200K Sep/2025
Genmab DKK 61.62M 52K Dec/2025
Gilead Sciences USD 1.24B 1000K Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
GRIFOLS EUR 680.58M 0 Mar/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Incyte USD 199.95M 1.49M Mar/2026
Merck EUR 434.78M 0 Dec/2025
Neurocrine Biosciences USD 100.6M 500K Mar/2026
Novartis USD 1.91B 60K Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
UCB EUR 190.36M 365.15K Dec/2025
Vertex Pharmaceuticals USD 254.2M 200K Mar/2026